These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35617800)

  • 1. CaMKII inhibition protects against hyperthyroid arrhythmias and adverse myocardial remodeling.
    Nie D; Xia C; Wang Z; Ding P; Meng Y; Liu J; Li T; Gan T; Xuan B; Huang Y; Zhang J; Su G; Li J
    Biochem Biophys Res Commun; 2022 Jul; 615():136-142. PubMed ID: 35617800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
    Kreusser MM; Lehmann LH; Keranov S; Hoting MO; Oehl U; Kohlhaas M; Reil JC; Neumann K; Schneider MD; Hill JA; Dobrev D; Maack C; Maier LS; Gröne HJ; Katus HA; Olson EN; Backs J
    Circulation; 2014 Oct; 130(15):1262-73. PubMed ID: 25124496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calmodulin kinase II inhibition protects against structural heart disease.
    Zhang R; Khoo MS; Wu Y; Yang Y; Grueter CE; Ni G; Price EE; Thiel W; Guatimosim S; Song LS; Madu EC; Shah AN; Vishnivetskaya TA; Atkinson JB; Gurevich VV; Salama G; Lederer WJ; Colbran RJ; Anderson ME
    Nat Med; 2005 Apr; 11(4):409-17. PubMed ID: 15793582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure.
    Sag CM; Wadsack DP; Khabbazzadeh S; Abesser M; Grefe C; Neumann K; Opiela MK; Backs J; Olson EN; Brown JH; Neef S; Maier SK; Maier LS
    Circ Heart Fail; 2009 Nov; 2(6):664-75. PubMed ID: 19919992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium/calmodulin-dependent protein kinase II causes atrial structural remodeling associated with atrial fibrillation and heart failure.
    Liu Z; Finet JE; Wolfram JA; Anderson ME; Ai X; Donahue JK
    Heart Rhythm; 2019 Jul; 16(7):1080-1088. PubMed ID: 30654134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CaMKII inhibition reduces isoproterenol-induced ischemia and arrhythmias in hypertrophic mice.
    Feng Y; Cheng J; Wei B; Wang Y
    Oncotarget; 2017 Mar; 8(11):17504-17509. PubMed ID: 28177919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CaMKII phosphorylation site Thr1604 in the Ca
    Li J; Wang S; Zhang J; Liu Y; Zheng X; Ding F; Sun X; Zhao M; Hao L
    Channels (Austin); 2020 Dec; 14(1):151-162. PubMed ID: 32290730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaMKII exacerbates heart failure progression by activating class I HDACs.
    Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
    J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
    Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME
    Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined transgenic inhibition of CaMKII and Ik1 on cardiac remodeling].
    Huang Y; Dai M; Du YM; Yao YF; Zhang JM; Su GH; Shu YW; Cui TP; Du XL; Li JD
    Sheng Li Xue Bao; 2015 Apr; 67(2):201-6. PubMed ID: 25896051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ageing Increases Cardiac Electrical Remodelling in Rats and Mice via NOX4/ROS/CaMKII-Mediated Calcium Signalling.
    Luo X; Yu W; Liu Z; Pu Z; Liu T; Li Y; Liu W; Lei M; Tan X; Chen T
    Oxid Med Cell Longev; 2022; 2022():8538296. PubMed ID: 35387264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of calmodulin/CaMKII activation for arrhythmogenesis in the AV block dog.
    Bourgonje VJ; Schoenmakers M; Beekman JD; van der Nagel R; Houtman MJ; Miedema LF; Antoons G; Sipido K; de Windt LJ; van Veen TA; Vos MA
    Heart Rhythm; 2012 Nov; 9(11):1875-83. PubMed ID: 22846339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca
    Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
    J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CaMKIIδC Drives Early Adaptive Ca
    Ljubojevic-Holzer S; Herren AW; Djalinac N; Voglhuber J; Morotti S; Holzer M; Wood BM; Abdellatif M; Matzer I; Sacherer M; Radulovic S; Wallner M; Ivanov M; Wagner S; Sossalla S; von Lewinski D; Pieske B; Brown JH; Sedej S; Bossuyt J; Bers DM
    Circ Res; 2020 Oct; 127(9):1159-1178. PubMed ID: 32821022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaMKII inhibition has dual effects on spontaneous Ca
    Sadredini M; Haugsten Hansen M; Frisk M; Louch WE; Lehnart SE; Sjaastad I; Stokke MK
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H446-H460. PubMed ID: 34270372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inositol Trisphosphate Receptors and Nuclear Calcium in Atrial Fibrillation.
    Qi XY; Vahdati Hassani F; Hoffmann D; Xiao J; Xiong F; Villeneuve LR; Ljubojevic-Holzer S; Kamler M; Abu-Taha I; Heijman J; Bers DM; Dobrev D; Nattel S
    Circ Res; 2021 Mar; 128(5):619-635. PubMed ID: 33375812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of calcium/calmodulin-dependent protein kinase type II delta does not mitigate adverse myocardial remodeling in volume-overloaded hearts.
    Mohamed BA; Elkenani M; Jakubiczka-Smorag J; Buchholz E; Koszewa S; Lbik D; Schnelle M; Hasenfuss G; Toischer K
    Sci Rep; 2019 Jul; 9(1):9889. PubMed ID: 31285482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRABP1 protects the heart from isoproterenol-induced acute and chronic remodeling.
    Park SW; Persaud SD; Ogokeh S; Meyers TA; Townsend D; Wei LN
    J Endocrinol; 2018 Mar; 236(3):151-165. PubMed ID: 29371236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.
    Liu N; Ruan Y; Denegri M; Bachetti T; Li Y; Colombi B; Napolitano C; Coetzee WA; Priori SG
    J Mol Cell Cardiol; 2011 Jan; 50(1):214-22. PubMed ID: 20937285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy.
    Wu Y; Temple J; Zhang R; Dzhura I; Zhang W; Trimble R; Roden DM; Passier R; Olson EN; Colbran RJ; Anderson ME
    Circulation; 2002 Sep; 106(10):1288-93. PubMed ID: 12208807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.